Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca
A Phase II Study of Allogeneic Large Multivalent Immunogen (LMI) Vaccine and IL-2 for the Treatment of Stable Metastatic Breast Cancer
Masonic Cancer Center, University of Minnesota